On June 9 and 10, 2003, FDA issued Warning Letters to 18 companies which operate 24 Internet sites advertising and marketing multiple coral calcium merchandise as efficient remedies or cures for a variety of diseases and situations. On February 11, 2003, Best Life International recalled Ancom Anti-Hypertensive Compound tablets, which were represented as dietary supplements however were discovered by FDA investigators to comprise a number of prescription drug components, together with reserpine, diazepam, promethazine, and hydrochlorothiazide. As well as, Global Source agreed to cease manufacturing, processing, packing, labeling, holding, or distributing "Vitamin Hut Scientific Cholesterol Support Program" or any comparable pink yeast rice product containing lovastatin or any other drug product that's a new drug until and till an permitted new drug software is in effect for such product. On July 22, 2003, FDA issued a Warning Letter to Ayoula Dublin, New York, New York, for marketing and distributing "Lipostabil", an injectable product that claimed to break down and dissolve fat "for the one who desires to lose those final 5-10 extra pounds". FDA will proceed to identify and take applicable enforcement actions in opposition to fraudulently marketed dietary complement products that make unsubstantiated medical claims of their labeling.

Viga, marketed as a dietary supplement, was found to comprise sildenafil, the active ingredient in Pfizer's Viagra. These products, that are marketed as dietary supplements, comprise a prescription drug ingredient, tadalafil, that poses health risks when taken with certain prescription medication containing nitrates. Moreover, the product’s construction/function claims and lack of substantiation to indicate that the product was generally acknowledged as safe and efficient for its supposed use made it a brand new drug without an accepted drug application. Moreover, though the products have been represented as dietary supplements, they didn't qualify as dietary supplements since they weren't intended for ingestion as set forth within the Act. Although the product claimed to be a dietary supplement, its route of administration disqualified it as a dietary supplement (because it was not intended for ingestion). Although the article is labeled as a "dietary complement," it is promoted by Kirkman Laboratories for autism on its Internet [webpage](http://classicrock.awardspace.biz/index.php?PHPSESSID=79b5d5bb6bb93623f0027ebb728a9846&action=profile